This inventor holds 5 USPTO granted patents. Top assignees: Nova Pharmaceutical Corporation, Guilford Pharmaceuticals, Inc., Marion Laboratories. Active years: 1987-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baltimore, MD (US) (1987 - 1991)
- Pasadena, MD (US) (1989 - 1995)
Company Filing History:
2 out of 23 
1 out of 98 
1 out of 50 Years Active: 1987-1995
Title: The Innovations of Maria E. Guzewska: A Pioneer in Neuroprotective Compounds
Introduction: Maria E. Guzewska is an accomplished inventor based in Pasadena, MD. With an impressive portfolio of five patents, she has made significant contributions to the fields of neuropharmacology and neuroprotection. Her work focuses on developing compounds that serve as antagonists to excitatory amino acid neurotransmitter receptors, with a view toward treating neurodegenerative diseases and anxiety disorders.
Latest Patents: Among her latest innovations are two noteworthy patents. The first patent pertains to .omega.-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists. This invention details a method for preparing these antagonists and their pharmaceutical compositions, which feature complex chemical formulations that are both versatile and effective in their application. The second patent addresses the use of 2-amino-.omega.-phosphonoalkanoic acids with cycloalkyl groups in developing neuroprotective and anxiolytic agents, aimed at treating neurodegeneration associated with chronic conditions affecting the central nervous system.
Career Highlights: Maria has worked with leading companies in the pharmaceutical industry, including Nova Pharmaceutical Corporation and Guilford Pharmaceuticals, Inc. Her expertise and passion for innovation have positioned her as a key figure in her field, driving forward the development of new therapies that address pressing neurological challenges.
Collaborations: Throughout her career, Maria has collaborated with notable professionals, including Waclaw J. Rzeszotarski and Suzanne R. Ellenberger. These collaborations have fostered a spirit of innovation and scientific advancement, amplifying her impact on the research community.
Conclusion: Maria E. Guzewska exemplifies the dedication and ingenuity of inventors committed to improving human health through their innovative work. With her continued contributions to neuropharmacology, she remains an influential figure in the development of therapies that may one day transform the treatment of neurodegenerative disorders and anxiety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile